BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 21171925)

  • 1. Tissular and soluble miRNAs for diagnostic and therapy improvement in digestive tract cancers.
    Albulescu R; Neagu M; Albulescu L; Tanase C
    Expert Rev Mol Diagn; 2011 Jan; 11(1):101-20. PubMed ID: 21171925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of miRNAs in gastrointestinal cancer diagnosis and prognosis.
    Song B; Ju J
    Expert Rev Mol Med; 2010 Oct; 12():e33. PubMed ID: 20942990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs: novel diagnostic and therapeutic tools for pancreatic ductal adenocarcinoma?
    Mardin WA; Mees ST
    Ann Surg Oncol; 2009 Nov; 16(11):3183-9. PubMed ID: 19636633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNAs: novel regulators in the hallmarks of human cancer.
    Ruan K; Fang X; Ouyang G
    Cancer Lett; 2009 Nov; 285(2):116-26. PubMed ID: 19464788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNAs are novel biomarkers of colorectal cancer.
    Aslam MI; Taylor K; Pringle JH; Jameson JS
    Br J Surg; 2009 Jul; 96(7):702-10. PubMed ID: 19526617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic and therapeutic potential of miRNA signatures in patients with hepatocellular carcinoma.
    Borel F; Konstantinova P; Jansen PL
    J Hepatol; 2012 Jun; 56(6):1371-83. PubMed ID: 22314424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNAs in gastrointestinal malignancy: a tool in cancer prevention?
    Mactier KE; Glaire MA; Basavaraju U; El-Omar EM; Hold GL
    Eur J Cancer Prev; 2014 Nov; 23(6):540-9. PubMed ID: 24608603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CEA, CA 19-9 and CA 72-4 improve the diagnostic accuracy in gastrointestinal cancers.
    Carpelan-Holmström M; Louhimo J; Stenman UH; Alfthan H; Haglund C
    Anticancer Res; 2002; 22(4):2311-6. PubMed ID: 12174919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNAs: new tools for diagnosis, prognosis, and therapy in hepatocellular carcinoma?
    Giordano S; Columbano A
    Hepatology; 2013 Feb; 57(2):840-7. PubMed ID: 23081718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of miRNA in carcinogenesis and biomarker selection: a methodological view.
    Ahmed FE
    Expert Rev Mol Diagn; 2007 Sep; 7(5):569-603. PubMed ID: 17892365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA expression and its implications for the diagnosis and therapeutic strategies of breast cancer.
    Shi M; Guo N
    Cancer Treat Rev; 2009 Jun; 35(4):328-34. PubMed ID: 19171434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNAs, ultraconserved genes and colorectal cancers.
    Rossi S; Kopetz S; Davuluri R; Hamilton SR; Calin GA
    Int J Biochem Cell Biol; 2010 Aug; 42(8):1291-7. PubMed ID: 19497386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miRNAs as molecular biomarkers of cancer.
    Fabbri M
    Expert Rev Mol Diagn; 2010 May; 10(4):435-44. PubMed ID: 20465498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA expression profiling in cancer from a bioinformatics prospective.
    Gusev Y; Brackett DJ
    Expert Rev Mol Diagn; 2007 Nov; 7(6):787-92. PubMed ID: 18020908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating biomarkers in neuroendocrine tumors of the enteropancreatic tract: application to diagnosis, monitoring disease, and as prognostic indicators.
    Ardill JE; O'Dorisio TM
    Endocrinol Metab Clin North Am; 2010 Dec; 39(4):777-90. PubMed ID: 21095544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [MicroRNAs: novel biomarkers for human cancer].
    Bartels CL; Tsongalis GJ
    Ann Biol Clin (Paris); 2010; 68(3):263-72. PubMed ID: 20478768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic applications of cell-free and circulating tumor cell-associated miRNAs in cancer patients.
    Mostert B; Sieuwerts AM; Martens JW; Sleijfer S
    Expert Rev Mol Diagn; 2011 Apr; 11(3):259-75. PubMed ID: 21463236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNAs as a new potential therapeutic opportunity in gastrointestinal cancer.
    Boni V; Bandres E; Zarate R; Colucci G; Maiello E; Garcia-Foncillas J
    Oncology; 2009; 77 Suppl 1():75-89. PubMed ID: 20130435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiRNAs as biomarkers and therapeutic targets in cancer.
    Heneghan HM; Miller N; Kerin MJ
    Curr Opin Pharmacol; 2010 Oct; 10(5):543-50. PubMed ID: 20541466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNAs: predictors and modifiers of chemo- and radiotherapy in different tumour types.
    Hummel R; Hussey DJ; Haier J
    Eur J Cancer; 2010 Jan; 46(2):298-311. PubMed ID: 19948396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.